Literature DB >> 11036135

Preemptive bupivacaine offers no advantages to postoperative wound infiltration in analgesia for outpatient breast biopsy.

D M O'Hanlon1, S T Colbert, P W Keane, F H Given.   

Abstract

BACKGROUND: Adequate analgesia is important after surgery and in particular after ambulatory surgery. Preemptive administration of analgesics, ie, prior to commencing surgery, has many theoretical advantages.
METHODS: In this prospective randomized study, the use of preincisional bupivacaine was compared with a postincision dose for the relief of postoperative pain, in 74 patients undergoing day-case breast biopsy.
RESULTS: Demographic criteria were similar in both groups. There were no differences in pain scores postoperatively on the visual analog scale (VAS): VAS at 30 minutes 4.5 ([SD] 2.4) versus 4.7 (1.9); P = not significant (NS); VAS at 60 minutes 3.3 (2. 3) versus 3.6 (2.2); P = NS; VAS at 120 minutes 1.9 (1.7) versus 2.5 (2.0); P = NS; VAS at 240 minutes 0.9 (1.0) versus 1.3 (1.4); P = NS. There was no difference in the number of patients requiring additional analgesia: 13 (36%) versus 18 (47%); P = NS. Nor was there a difference in the time to additional analgesia: 55.0 (37.8) versus 55.3 (39.2) minutes; P = NS.
CONCLUSIONS: The administration of local anaesthesia prior to starting surgery does not appear to have any advantage over its postoperative administration in patients undergoing ambulatory breast biopsy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036135     DOI: 10.1016/s0002-9610(00)00413-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  A double blind randomized trial of wound infiltration with ropivacaine after breast cancer surgery with axillary nodes dissection.

Authors:  Axelle Vigneau; Anne Salengro; Joelle Berger; Roman Rouzier; Emmanuel Barranger; Emmanuel Marret; Francis Bonnet
Journal:  BMC Anesthesiol       Date:  2011-11-24       Impact factor: 2.217

2.  Morphine after tubal ligation with bupivacaine: dosage versus body weight.

Authors:  Bryan C Roehl; Sarah J Breese McCoy; Mark E Payton; LouAnn C Witter
Journal:  JSLS       Date:  2014 Oct-Dec       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.